Lung Cancer

EDU 31 - (INTERACTIVE) Challenging Cases in Lung Cancer: Oligometastatic Disease

Chemotherapeutic Management of Oligometastatic NSCLC

Speaker(s)

• ME

  Martin Edelman, MD

  Fox Chase Cancer Center

  Employment
  University of Maryland: Professor of Medicine: Employee
  
  Compensation
  Astra Zeneca: DSMB; Bristol Myers Squibb: Research Grants
  
  Ownership
  Andarix: Stock Options; Biomarker Strategies: Stock Options
  
  Leadership
  Alliance for Clinical Trials in Oncology: Board of Directors; ASCO: Chair, Education Committee (Lung Cancer); NRG: Co-chair, Lung Committee